Your Client’s Big Tech Company Just IPO’d. Now What?

“The post-IPO wealth-management playbook in the article overstates practical access and tax advantages while underappreciating liquidity and concentration risks, making real-world outcomes more conditional and less straightforward.”

While the article highlights the need for a capital plan after an IPO, it glosses over real frictions. Taxes at vesting for RSUs, AMT/ISO complications, and the high costs and illiquidity of tools like donor-advised funds and exchange funds can blunt the supposed tax savings. Lockups are not mere 'deadlines' but a liquidity and price-risk constraint, and the six-to-twelve month window can trigger costly, premature diversification. Accessibility is overstated: many clients face high minimums, fees, and complexity that deter effective implementation, leaving tail risk and concentration intact longer than the piece implies.

“The impending wave of insider selling post-lockup creates a structural liquidity risk that could trigger a significant repricing of high-valuation AI stocks.”

The article frames IPO liquidity as a wealth management hurdle, but it ignores the systemic risk of 'lockup expiration overhang.' When high-beta AI darlings like Anthropic or OpenAI hit public markets, the sheer volume of insider shares hitting the float post-lockup creates massive supply-demand imbalances. Advisors focusing solely on tax-efficient divestment miss the volatility risk; if these employees dump stock simultaneously, they trigger a price collapse that destroys the very capital they aimed to diversify. We are looking at a potential liquidity trap where the market cannot absorb the supply, leading to a 'sell-the-news' event that could drag down the broader Nasdaq-100 index.

“The article conflates tax efficiency with fiduciary advice, when the real question is whether diversification serves the client's goals or the advisor's fee structure.”

This article frames post-IPO wealth management as a planning problem, but it's actually a tax arbitrage opportunity disguised as risk management. The real issue: advisors pushing exchange funds, donor-advised funds, and separately managed accounts are often extracting 0.5–1.5% in fees annually while clients sit in lockup, unable to execute diversification anyway. The article assumes concentrated positions are inherently dangerous, but a $50M position in a profitable, growing AI company might be the best risk-adjusted asset a client owns. The tax-loss harvesting and charitable strategies mentioned are legitimate, but they're being sold as urgent when most clients have 6–12 months to decide. The unstated conflict: advisors benefit from AUM on diversified portfolios far more than from a client holding one mega-position.

“Standard tax-deferral tactics for concentrated AI IPO stock ignore the larger risk of rapid multiple contraction in an already stretched sector.”

The article frames post-IPO lockup expiration as a tax and concentration problem for employees at SpaceX, Anthropic, and OpenAI, pushing long-short SMAs, donor-advised funds, and exchange funds. What it underplays is the liquidity and fee drag these vehicles impose—exchange funds often require 7-year commitments and 1-2% annual costs—while AI names trade at 30-50x revenue with minimal profits. If multiples compress even 30%, the tax savings from deferral could be swamped by principal loss. Advisors should model downside scenarios before locking clients into illiquid structures.